In this file
Before budgeting for Ivím Health, identify the event that produces a charge: joining a care program, buying a prescription, renewing a package, or booking a consultation. Those events can happen on different dates.
The main pricing detail in the documents is: Six-month drug offers and monthly membership create two payment questions. Below, we distinguish the published figures from calculations and items that still require a personal quote.
Start with the published offer
Displayed six-month medication equivalents are $75 for semaglutide and $133 for tirzepatide. A separate membership is $75 per month with an advertised free first month. If the semaglutide and membership terms apply together, six drug months plus five membership months would be $825. That calculation is illustrative until confirmed for the selected offer.
Ivím describes ongoing weight-management support through a membership alongside medication programs. Its homepage also presents patient-outcome research; that observational program evidence should be distinguished from a randomized test of a specific compounded product.
Build a complete payment picture
Ask Ivím Health for a dated summary with four lines: the amount due at enrollment, any separate medicine charge, the amount due at the next refill, and the total obligation under the chosen term. If no prescription has been issued, ask which parts can change after clinical assessment.
Add required care and testing to medication before comparing providers. A price per dose, a price per four weeks, and a calendar-month subscription cannot be compared simply by placing their headline numbers together. Start with the same treatment period and then compare the money needed upfront.
Check the commitment behind the saving
The terms describe conditions and cancellation fees for unused portions of longer medication plans, with an exception involving a provider’s medical-ineligibility determination. The examples are plan-specific; there is no basis to apply one fee to every term.
A prepaid discount exchanges flexibility for a lower stated average. Financing may spread payments while leaving the full obligation in place. Ask what happens if treatment stops, changes, or cannot be prescribed, and whether that affects the medicine payment, membership, or both.
Make the clinical comparison match
Clinical check-ins and individualized prescribing are described, but the actual pharmacy, ingredients, refill process, and expiration of a plan should be confirmed. A six-month purchase does not establish that six identical shipments arrive on one schedule.
Do not budget for a different route or a starter prescription merely because it is cheaper. The clinician determines the treatment; the financial comparison should then describe that actual product and the care that accompanies it.
A practical quote request
Does the membership remain necessary during the full prepaid medication period, and how are the two charges cancelled?
The published telephone number for Ivím Health is (877) 581-2210. An email route appears at support@ivimhealth.com.
For questions about an existing bill, use the Ivím Health contact file and keep the charge date, statement description, and receipt available. Use secure channels for any treatment record.
Read the connected files
The Ivím Health provider file connects the cost details, support routes, and cancellation questions so that the same plan can be checked from more than one angle.
To compare several offers on the same basis, use the GLP-1 price worksheet. It separates a low initial payment from an affordable ongoing plan.
Source notes
Provider material describes the company’s own offer. Official medical references explain clinical and regulatory context; they do not endorse this publication or its commercial partner.
- Ivím Health – Individualized Health & Wellness Programs ↗Provider-published information · Checked September 22, 2026
- Terms and Conditions – Ivím Health ↗Provider-published information · Checked September 22, 2026
- Ivím Health: refill process and support contacts ↗Provider-published information · Checked September 22, 2026
- FDA: concerns with unapproved GLP-1 drugs ↗Regulatory / public agency · Checked September 22, 2026